Immune checkpoint silencing using RNAi-incorporated nanoparticles enhances antitumor immunity and therapeutic efficacy compared with antibody-based approaches
- J. Immunother. Cancer, First published February 28, 2022 | http://dx.doi.org/10.1136/jitc-2021-003928